A Study to Evaluate the Efficacy and Tolerability of a Second-line Triple Regimen of Moxifloxacin, Amoxicillin and Esomeprazole in Patients with Helicobacter Pylori Infection who Failed the Previous Treatment

Trial Profile

A Study to Evaluate the Efficacy and Tolerability of a Second-line Triple Regimen of Moxifloxacin, Amoxicillin and Esomeprazole in Patients with Helicobacter Pylori Infection who Failed the Previous Treatment

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Dec 2015

At a glance

  • Drugs Amoxicillin (Primary) ; Esomeprazole (Primary) ; Moxifloxacin (Primary)
  • Indications Helicobacter infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top